Acute Lung Injury and the Acute Respiratory Distress Syndrome: Challenges in Clinical Trial Design
Authors:
- Todd W. RiceTRTodd W. Rice
- Gordon R. BernardGBGordon R. Bernard
- 1 December 2006
- journal article
- review article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 27 (4) , 733-754
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Epidemiology of acute lung injuryCritical Care Medicine, 2003
- Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndromeCritical Care Medicine, 2002
- Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndromeCritical Care Medicine, 2002
- Influence of direct and indirect etiology on acute outcome and 6-month functional recovery in acute respiratory distress syndromeCritical Care Medicine, 2001
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patientsCritical Care Medicine, 2000
- Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndromeCritical Care Medicine, 1999
- High-Dose Corticosteroids in Patients with the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1987